"Outwalk MS" - Benefits of Outdoor Walking in Multiple Sclerosis
1 other identifier
interventional
60
1 country
1
Brief Summary
Deterioration of walking capacity is a common symptom in persons with multiple sclerosis (pwMS), furthermore having a negative influence on well-being. Studies have nevertheless shown that walking exercise therapy can improve walking capacity in pwMS. This may be particularly potent if occurring outdoors due to the varying stimuli it can provide (different surfaces and terrain etc.), and if the intensity and duration is adequate. Furthermore, outdoor walking is (1) suitable as a group intervention facilitating interaction between pwMS and (2) advantageous due to the health benefits offered through the interaction with nature itself. Both these aspects are also relevant for well-being. Few studies have nevertheless examined the effects of outdoor walking exercise therapy in pwMS. The purpose of the present study is therefore to examine the effects of 7 weeks of moderate-to-high intensity outdoor walking exercise therapy on walking capacity (primary outcome: 6-minute walk test) and well-being in pwMS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable multiple-sclerosis
Started Nov 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2021
CompletedFirst Submitted
Initial submission to the registry
November 25, 2021
CompletedFirst Posted
Study publicly available on registry
June 13, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2022
CompletedSeptember 1, 2023
November 1, 2021
9 months
November 25, 2021
August 31, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
6-minutes walk test (6MWT)
Maximal distance covered in 6 minutes using a 30 meter walkway. Assesses walking endurance.
Change from baseline (Pre) to after 7 weeks intervention (Post)
Secondary Outcomes (19)
6-minutes walk test (6MWT)
Change from baseline (Pre) to 24 weeks follow-up (Follow-up)
Timed 25-foot walk test (T25FWT)
Change from baseline (Pre) to after 7 weeks intervention (Post)
Timed 25-foot walk test (T25FWT)
Change from baseline (Pre) to 24 weeks follow-up (Follow-up)
Six spot step test (SSST)
Change from baseline (Pre) to after 7 weeks intervention (Post)
Six spot step test (SSST)
Change from baseline (Pre) to 24 weeks follow-up (Follow-up)
- +14 more secondary outcomes
Study Arms (2)
Walking exercise therapy
EXPERIMENTAL7 week intervention group. 6-12 persons per group. 2 sessions per week, 14 sessions in total. Surface: the investigators aim to involve as much forest/gravel trails as possible, with up/down hill walking. Uneven session numbers: warm-up (6 minutes at BORG 10-11), continous walking (starting at 12-20 minutes at BORG 13-14 and progressing to 20-40 minutes at BORG 15-16, adjusted according to the starting level of each participant) and cool-down (approximately 10 minutes at BORG 10-11). Even session numbers: warm-up (6 minutes at BORG 10-11), intermittent walking (starting at 3-4 intervals of 2 minutes at BORG 14-15 and progressing to 4-5 intervals of 2-3 minutes at BORG 16-17; with all intervals being interspersed by 1 minute rest) and cool-down (approximately 10 minutes at BORG 10-11).
Control/Waitlist
NO INTERVENTION7 week control/waitlist group. Continuation of habitual lifestyle during the 7 week intervention period (yet these participants will receive the exact walking exercise therapy afterwards).
Interventions
Moderate-to-high intensity walking exercise therapy (7 weeks, 14 session) with progression in duration and intensity.
Eligibility Criteria
You may qualify if:
- ≥ 18 years
- self-reported clinical MS diagnosis
- PDDS ≤ 4 (corresponding to preserved walking capacity without assistive devices of at least 10 m)
- able to independently attend the testing
You may not qualify if:
- self-reported comorbidities excluding participation in the intervention
- recent (6 months retrospective) fractures, amputation or other critical physical impairments that eliminates participation in the described training study
- participation in structured exercise therapy (including walking) for the past 3 months (≥ 2 session per week of moderate-to-high intensity)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Aarhuslead
- The Danish MS Societycollaborator
Study Sites (1)
Aarhus University, Health, Exercise Biology
Aarhus, Jutland, 8000, Denmark
Related Publications (1)
Hvid LG, Steenberg JL, Roy F, Skovgaard L. Outdoor walking exercise therapy improves walking capacity and well-being in persons with multiple sclerosis: A randomized controlled trial. Ann Phys Rehabil Med. 2025 Sep;68(6):101985. doi: 10.1016/j.rehab.2025.101985. Epub 2025 Apr 18.
PMID: 40252300DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lars G Hvid, MSc, PhD
Aarhus University, Department of Public Health, Exercise Biology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 25, 2021
First Posted
June 13, 2022
Study Start
November 1, 2021
Primary Completion
July 31, 2022
Study Completion
November 30, 2022
Last Updated
September 1, 2023
Record last verified: 2021-11